DDi is an innovative Technology product company specializing in Regulatory, Clinical, Safety, and Enterprise domains by providing innovative technology products and automation solutions for companies of various sizes. Founded in 1996 and based in United States, DDi offers a wide range of solutions including Regulatory Intelligence, Regulatory Affairs Automation, RIM (Product, Registrations, Submissions), Structure Content Authoring, Technical/Regulatory Writing Automation, E2E labeling Labe Management, Eudamed/UDI solutions, and eIFU Management. In addition, DDi provides Clinical Solutions such as IRT/RTSM solutions, Clinical Supplies & Randomization, CRO Oversight platform, and RBM (Risk Based Monitoring).
With its focus on Clinical, Regulatory & Automation Solutions, DDi caters to various industries and has proven to be a valuable asset for companies looking to enhance their regulatory and clinical operations. While specific investment details and investors are currently unavailable, DDi's extensive range of technology products and automation solutions positions it as a promising prospect for potential venture capital interests seeking opportunities within the clinical and regulatory technology space.